- CAVATAS investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Transluminal Angioplasty Study (CAVATAS): a randomized study. Lancet 2001; 357: 1729-37.
- Brooks WH, McClure RR, Jones MJ, et al. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol 2001; 38: 1589-95.
- Roubin GS, New G, Iyer SS,et al. Immediate and late outcomes of carotid angioplasty and stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation 2001; 103: 532-37.
- Naylor AR, Bolia A, Abbott RJ, et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg 1998; 28: 326-34.
- Alberts MJ for the publications committee of the WALLSTENT trial. Results of a multicenter prospective randomized study of carotid artery stenting versus carotid endarterectomy. Stroke 2001; 32: 325(abstr).
- EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
- EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336: 1689-96.
- EPISTENT investigators. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 1998; 352: 87-92.
- Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. Blood 1985; 66: 1456-59.
- Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33-42.
- Lefkovits J, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N Engl J Med 1995; 332: 1553-59.
- Pope CF, Ezekowitz MD, Smith EO, et al. Detection of platelet deposition at the site of peripheral balloon angioplasty using Indium-111 platelet scintigraphy. Am J Cardiol 1985; 55: 495-97.
- Wilentz JR, Sanborn TA, Haudenschild CC, et al. Platelet accumulation in experimental angioplasty: time course in relation to cardiovascular injury. Circulation 1987; 75: 636-42.
- Gawaz A, Neumann FJ, Ott I, May A, Schomig A. Platelet activation and coronary stent implantation: effect of antithrombotic therapy. Circulation 1996; 94: 279-85.
- Gawaz A, Ott I, Neumann FJ. Surface expression of platelet membrane glycoproteins following coronary stenting: effect on subacute stent thrombosis? Circulation 1994; 90(suppl I): I-552 (abstr).
- Anderson JH, Gianturco C, Wallace S, Dodd GD. A scanning microscopic study of angiographic catheters and guide wires. Radiology 1974; 111: 567-71.
- Krupski WC, Bass A, Kelly AB, Marzec UM, Hanson SR, Harker KA. Heparin-resistant thrombus formation by endovascular stents in baboons. Circulation 1990; 82: 570-77.
- Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101: 570-80.
- Eguchi H, Ikeda H, Murohara T, et al. Endothelial injuries of coronary arteries distal to thrombotic sites: role of adhesive interaction between endothelial P-selectin and leukocyte sialyl Lewis X. Circ Res 1999; 84: 525-35.
- Le Breton H, Plow EF, Topol EJ. Role of platelets in restenosis after percutaneous coronary revascularization. J Am Coll Cardiol 1996; 28: 1643-51.
- Jordan WD Jr, Voellinger DC, Doblar DD, Plyusheva NP, Fisher WS, McDowell HA. Microemboli detected by transcranial doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg 1999; 7: 33-38.
- Qureshi AI, Suri M, Fareed K, et al. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery 2000; 46: 1316-25.
- Mathur A, Roubin GS, Iyer SS, Piamsonboon C, et al. Predictors of stroke complicating carotid artery stenting. Circulation 1998; 97: 1239-45.
- Qureshi AI, Luft AR, Janardhan V, et al. Identification of patients at risk for periprocedural neurological deficits associated with carotid angioplasty and stenting. Stroke 2000; 31: 376-82.
- Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) trial: Part I - hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11: 1-11.
- Kapadia SR, Bajzer CT, Ziada KM, et al. Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. Stroke 2001; 32: 2328-32.
- Schneiderman J, Morag B, Gerniak A. Abciximab in carotid stenting in postsurgical carotid restenosis: intermediate results. J Endovasc Ther 2000; 7: 263-72.
- Qureshi AI, Suri MFK, Ali Z, et al. Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenous abciximab. Neurosurgery 2002; (in press).
- The CAPTURE investigators. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 1997; 349: 1429-35.
- Akkerhuis K, Deckers JW, Lincoff AM, et al. Risk of stroke associated with abciximab among patients undergoing percutaneous coronary intervention. JAMA 2001; 286: 78-82.
- Qureshi AI, Saad M, Zaidat O, et al. Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab. Stroke 2002; (in press).
- Nikolsky E, Patil C, Beyar R. Ipsilateral intracerebral hemorrhage following carotid stent-assisted angioplasty: a manifestation of hyperperfusion syndrome. Angiology 2002; 53: 217-23.
- McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke 1999; 30: 2483-86.
- Gonzalez A, Mayol A, Gil-Peralta A, et al. Hyperperfusion syndrome as a complication of percutaneous transluminal angioplasty of the internal carotid artery. Rev Neurol 1999; 29: 923-25.
- Schoser BG, Heesen C, Eckert B, et al. Cerebral hyperperfusion injury after percutaneous transluminal angioplasty of extracranial arteries. J Neurol 1997; 244: 101-104.
- The Abciximab in Ischemic Stroke Investigators. Abciximab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose escalation study. Stroke 2000; 31: 601-609.
- Ouriel K, Shortell CK, Illig KA, Greenberg RK, Green RM. Intracerebral hemorrhage after carotid endarterectomy: incidence, contribution to neurologic morbidity, and predictive factors. J Vasc Surg 1999; 29: 82-87.
- Sundt TM. The ischemic tolerance of neural tissue and the need for monitoring and selective shunting during carotid endarterectomy. Stroke 1983; 14: 93-98.
- MacFarlane R, Moskowitz MA, Sakas DE, et al. The role of neuroeffector mechanisms in cerebral hyperperfusion syndromes. J Neurosurg 1991; 75: 845-55.
- Epstein AE, Halstrom AP, Rogers WJ, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction: the original design concept of the Cardiac Arrhythmia Suppression Trial (CAST). JAMA 1993; 270: 2451.
International Journal of Cardiovascular Interventions
Volume 5, 2003 - Issue 2